Trial NCT00742339

View at ClinicalTrials.gov 
Org. Study IDs: 1264P

Last trial update was posted on 2014-10-15

MeSH Interventions

Midodrine Octreotide Terlipressin

MeSH Conditions

Fibrosis Hepatorenal Syndrome Liver Cirrhosis Syndrome

Other Conditions

Cirrhosis

Stopping Reasons

Decision of independent monitoring committee: Risk of non-response to treatment significantly higher in midodrine group than in terlipressin group.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID